Loading candles…
Epigral Limited, incorporated in 2007 and formerly known as Meghmani Finechem Ltd, is an integrated chemical manufacturer based in India. It operates a fully integrated and automated manufacturing complex located in Dahej, Gujarat, which is designed with backward and forward integration and established infrastructure. The company produces a range of chemicals, including Epichlorohydrin (ECH), Chlorinated Polyvinyl Chloride (CPVC) resin, Caustic Soda, Caustic Potash, Chloromethanes, Hydrogen Peroxide, Chlorine, and Hydrogen. Epigral Limited serves industries such as chemicals, textiles, alumina, paper, and pharmaceuticals. It is noted for being the first company in India to establish an Epichlorohydrin plant and operates the largest Chlorinated Polyvinyl Chloride resin capacity in the country. The company has no listed subsidiaries or ventures and is not listed on any stock exchanges.
This page is a live market overview for EPIGRAL LIMITED (EPIGRAL) on the NSE. As a listed security, EPIGRAL LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for EPIGRAL before placing trades on tick2trade.
As of the latest feed, EPIGRAL last traded at ₹1,101.2 on NSE, up ₹5.4 (0.49%) from the previous close of ₹1,095.8. Today's session range is ₹1,092.7 – ₹1,112, against a 52-week band of ₹807 – ₹1,938.9. Traded volume today stands at 17.38K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for EPIGRAL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether EPIGRAL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for EPIGRAL LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in EPIGRAL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated EPIGRAL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | To consider and approve the Un-Audited Financial Results for the First quarter ended 30th June, 2026. | 27 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 2 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 30 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 10 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and Fund Raising | 2 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 5 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.